Samsung Bioepis Gets US Adalimumab Nod

Counting
Samsung Bioepis now boasts US biosimilars of all three first-generation anti-TNF biologics • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products